Amber Salzman is a distinguished leader in the HealthTech industry currently serving as the CEO of Epic Bio. With a robust background in therapy development she has dedicated her career to addressing unmet medical needs. Previously Amber was the CEO and President of Ohana Biosciences and led Adverum Biotechnologies focusing on gene therapy for rare diseases. In addition to her corporate roles Amber actively contributes to healthcare improvement initiatives